Administration for Strategic Preparedness & Response (ASPR) Offers COVID-19 Therapeutic Resources
The Administration for Strategic Preparedness and Response (ASPR) leads the nation’s medical and public health preparedness for, response to, and recovery from disasters and public health emergencies. In the process of accomplishing its mission, ASPR partners with hospitals, healthcare coalitions, biotech firms, community organizations, advocacy groups and with state, local, tribal, and territorial governments.
ASPR is working with our partners to help ensure an equitable response to the COVID-19 pandemic. Efforts to address COVID-19 include the provision of access to life-saving medicines; deployment of medical supplies and equipment from the Strategic National Stockpile; and supporting the research, development, and acquisition of tests, treatments, and vaccines. On a more local level, ASPR offers technical assistance, resources, and tools to help public health and medical professionals respond to the pandemic in their communities.
COVID-19 Therapeutic Resources
1. ASPR COVID-19 Therapeutics page: Main ASPR COVID-19 Therapeutics webpage covering product and FDA Emergency Use Authorization updates and other featured resources focused on COVID-19 therapeutics that can be used to prevent or treat eligible non-hospitalized patients with mild to moderate COVID-19 symptoms. Prevention and early treatment for eligible patients can help improve patient outcomes, reduce stress on healthcare facilities, and even save lives. Early intervention with COVID‑19 therapeutics has been shown to reduce the risk of severe illness, hospitalization, and death for people with COVID‑19 who are at high risk of progressing to severe disease.
2. Clinical Resources for Healthcare Care Providers
- Clinical Implementation Guide: In-depth look at all outpatient therapeutics.
- Decision Aid: Quick reference guide for providers to assist with identifying treatment for patients.
- Side by Side Overview: Side-by-side comparison of available outpatient therapeutics.
- Therapeutics Locator tool: Interactive map to help providers find locations where patients can fill prescriptions or receive treatment.
- Therapeutic Videos & Resources: Video descriptions of outpatient treatment options, ASPR’s work to ensure products are distributed equitably, and an extensive resource section.
- FDA Checklist: Patient Eligibility Screening Checklist Tool for Prescribers
- NIH COVID-19 Treatment Guidelines: Frequently updated clinical guidance for providers to aid COVID-19 patient care, reflecting newly published data and other authoritative information.
- CDC High Risk Guidance: An updated list of high-risk underlying conditions, along with the associated evidence and guidance.
- Liverpool COVID-19 Interaction Tracker: Freely available drug interactions resource to provide information on the likelihood of interactions between the experimental agents used for treatment of COVID-19 and commonly prescribed co-medications.
3. Patient Resources
- COVID-19 Patient Journey: What to do when a patient first thinks they are sick or have been exposed to COVID-19
- Treatment Options for COVID-19: Information for the general public on the different COVID-19 therapeutics
- Test to Treat locator tool: Interactive map identifying nearby Test to Treat sites and available COVID-19 therapeutics. Home delivery and telehealth options are available.
- Test to Treat (T2T) National InitiativeTest to Treat Initiative: program background, finding participating Test to Treat sites, CDC COVID-19 hotline, and disability resources
- Home Test Kits: Free at home test kits available to order
4. Outreach Resources
- The Digital Toolkit contains messages you can share on your social media channels to encourage people to learn more about these COVID-19 therapeutic resources. Features such as downloadable text messages, images, and graphics to match social platforms are available.
- Digital Toolkit for Rural Health and Telehealth – Coming Soon! Social media content highlighting access to COVID-19 therapeutics for rural communities and through telehealth.
Other Agency Resources
1. ASPR TRACIE (Technical Resources, Assistance Center, and Information Exchange) is a healthcare emergency preparedness information gateway that ensures that all stakeholders have access to information and resources to improve preparedness, response, recovery, and mitigation efforts.
- The ASPR TRACIE quick sheet, along with the ASPR TRACIE Rural Health and COVID-19 considerations resource, identifies challenges faced by rural areas specific to COVID-19.
- Additional non-COVID-19 resources:
- Homecare and Hospice
- Rural Disaster Health
- Disasters and Healthcare Disparity
- Hospital-Based Incident Command Systems: Small and Rural Hospitals
- ASPR TRACIE TA: Rural Hospital Emergency Operations Plans
- Medical Surge and the Role of Health Clinics
- Medical Surge and the Role of Home Health and Hospice Agencies
- Mass Shootings and Rural Areas
- Fatality Management in Rural Areas: How One Justice of the Peace Oversaw the Uvalde School Shooting
- Solar Eclipses: Planning Resources
2. Health Resources and Service Administration (HRSA) – HRSA programs provide equitable health care to people who are geographically isolated and economically or medically vulnerable. HRSA continues to expand COVID-19 Response in Rural Communities through Rural Health Clinics including, but not limited to, testing, therapeutics, and equitable vaccine distribution.
- COVID-19 Information – Federal Office of Rural Health Policy
- Rural Health Clinic (RHC) COVID-19 Programs Infographic
- Expanding COVID-19 Response in Rural Communities through Rural Health Clinics Fact Sheet
- Rural Response to Coronavirus Disease 2019 (COVID-19) Overview – Rural Health Information Hub
- NARHC- HRSA Rural Health Clinic COVID-19 Therapeutics Program and associated FAQs
- Additional non-COVID-19 resources:
HRSA RHC Vaccines: RHCVaxDistribution@hrsa.gov
HRSA RHC Testing Supplies: RHCTestKit@hrsa.gov
HRSA RHC Therapeutics: RHCTreatment@hrsa.gov
Additional COVID-19 questions? Contact ASPR at COVID19therapeutics@hhs.gov
Our website links to federal agencies and, in some cases, to private organizations. You are subject to those sites’ privacy policies when you leave our site.
Reference in this website to any specific commercial product, process, service, manufacturer, or company is not an endorsement or recommendation by the U.S. Government or the U.S. Department of Health and Human Services (HHS). HHS is not responsible for the contents of other websites.
When visiting our website, your browser may also produce pop-up advertisements. These advertisements were most likely produced by other websites you visited or third-party software on your computer. HHS does not endorse or recommend products or services for which you may see a pop-up advertisement while visiting our site.